WHAT LOOKS LIKE A PHARMACY BENEFIT SOMETIMES ISN’T: THE J-CODE CONUNDRUM
PUBLISHED
August 26th, 2025
Chris Antypas
From what I’ve seen, more than three quarters of employers are facing at least one J-code issue. And because medically administered and infused drugs are being prescribed at higher and higher rates, risk and costs to employers are increasing. It’s (…)
There’s more to Read
